We hope that these early findings can usher in new treatment options for PVR and other eye diseases.” PVR is scar tissue that forms inside the eye ... please contact the cited source. Our press ...

Excessive drinking can damage the liver. Yet, unlike obesity or high cholesterol, clinicians only screen for alcohol use by ...

Syntara Limited (ASX:SNT), a clinical-stage drug development company, is pleased to announce positive interim data from its ongoing Phase 2 clinical trial evaluating SNT-5505 (200 mg BID) in ...

So, new attempts to repair scar tissue in infarcted hearts using cells or cell products ... This message is part of a critical review of cell-based and cell product-based therapies for the treatment ...

WHISTLE-PF will test the efficacy of various daily oral doses of ENV-101 against a placebo in adults with idiopathic ...

Refoxy Pharmaceuticals GmbH is a preclinical biotech company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases. Today, the company ...

The positive opinion could lead to the first approval of a therapy for these conditions in children ... Ofev works by ...

A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s diseasePrimary endpoints met in ...

If physical therapy is advised ... Manual techniques like myofascial release can aid with healing and help reduce the amount of scar tissue that develops. The excessive buildup of scar tissue can lead ...

Athletes who undergo ablation to treat their irregular heartbeat caused by atrial fibrillation (AF) experience greater ...